Empowering You to Take Charge of Your Treatment

Patients living with advanced prostate cancer need to understand all of their options. In this webinar, a doctor and patient discussed what it's like to live with advanced prostate cancer, patient empowerment, immunotherapy as a treatment option, barriers to care, and the specifics of Provenge® , the only FDA-approved immunotherapy for metastatic castration-resistant prostate cancer (mCRPC).

The presentation and conversation featured Dr. Damian Sorce, M.D. and prostate cancer survivor, Mr. Euvon Jones. We will discuss living with prostate cancer, patient empowerment, immunotherapy as a treatment option, barriers to care, and the specifics of Provenge®, the only FDA-approved immunotherapy for mCRPC.

Meet our Presenters

Dr. Damian Sorce

Dr. Damian Sorce, M.D.

Director, Advanced Prostate Cancer Clinic
Euvon Jones

Euvon Jones

Patient

See More Videos

From webinars, to presentations at the ZERO Prostate Cancer Summit and Health Equity Symposium, to the "Ask the Doctor" series, patient stories, and archives of Facebook Live, learn about prostate cancer with ZERO's video libraries.

Brought to You in Partnership with:

Share